
Ryan N. Henderson
Examiner (ID: 2057, Phone: (571)270-1430 , Office: P/3779 )
| Most Active Art Unit | 3795 |
| Art Unit(s) | 3739, 3795, 3779 |
| Total Applications | 931 |
| Issued Applications | 516 |
| Pending Applications | 102 |
| Abandoned Applications | 329 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6154835
[patent_doc_number] => 20110023151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'GENOME EDITING OF ABC TRANSPORTERS'
[patent_app_type] => utility
[patent_app_number] => 12/842982
[patent_app_country] => US
[patent_app_date] => 2010-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 19367
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20110023151.pdf
[firstpage_image] =>[orig_patent_app_number] => 12842982
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/842982 | GENOME EDITING OF ABC TRANSPORTERS | Jul 22, 2010 | Abandoned |
Array
(
[id] => 6196587
[patent_doc_number] => 20110028345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'METHODS TO CHARACTERIZE CELL REPROGRAMMING AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/837729
[patent_app_country] => US
[patent_app_date] => 2010-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 23757
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20110028345.pdf
[firstpage_image] =>[orig_patent_app_number] => 12837729
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/837729 | METHODS TO CHARACTERIZE CELL REPROGRAMMING AND USES THEREOF | Jul 15, 2010 | Abandoned |
Array
(
[id] => 8184015
[patent_doc_number] => 20120114613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'DEFINITIVE ENDODERM CELL POPULATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/836275
[patent_app_country] => US
[patent_app_date] => 2010-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 13957
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20120114613.pdf
[firstpage_image] =>[orig_patent_app_number] => 12836275
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/836275 | Cell population enriched for endoderm cells | Jul 13, 2010 | Issued |
Array
(
[id] => 5975799
[patent_doc_number] => 20110070203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-24
[patent_title] => 'MESENDODERM AND MESODERM CELL POPULATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/836277
[patent_app_country] => US
[patent_app_date] => 2010-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 13958
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20110070203.pdf
[firstpage_image] =>[orig_patent_app_number] => 12836277
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/836277 | MESENDODERM AND MESODERM CELL POPULATIONS | Jul 13, 2010 | Abandoned |
Array
(
[id] => 7563214
[patent_doc_number] => 20110277048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-10
[patent_title] => 'Transgenic Aves Producing Human Polyclonal Antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/835721
[patent_app_country] => US
[patent_app_date] => 2010-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 20498
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0277/20110277048.pdf
[firstpage_image] =>[orig_patent_app_number] => 12835721
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/835721 | Transgenic Aves Producing Human Polyclonal Antibodies | Jul 12, 2010 | Abandoned |
Array
(
[id] => 8429653
[patent_doc_number] => 20120251528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'Non-Human Mammal Model Of Human Hematopoietic Cancer'
[patent_app_type] => utility
[patent_app_number] => 13/381307
[patent_app_country] => US
[patent_app_date] => 2010-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10215
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13381307
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/381307 | Non-Human Mammal Model Of Human Hematopoietic Cancer | Jun 27, 2010 | Abandoned |
Array
(
[id] => 9850482
[patent_doc_number] => 08952214
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-10
[patent_title] => 'Animal model for chronic obstructive pulmonary disease and cystic fibrosis'
[patent_app_type] => utility
[patent_app_number] => 12/823243
[patent_app_country] => US
[patent_app_date] => 2010-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 38
[patent_no_of_words] => 5742
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12823243
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/823243 | Animal model for chronic obstructive pulmonary disease and cystic fibrosis | Jun 24, 2010 | Issued |
Array
(
[id] => 8289829
[patent_doc_number] => 20120178158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-12
[patent_title] => 'ADULT ANIMALS GENERATED FROM INDUCED PLURIPOTENT CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/379590
[patent_app_country] => US
[patent_app_date] => 2010-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16550
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13379590
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/379590 | ADULT ANIMALS GENERATED FROM INDUCED PLURIPOTENT CELLS | Jun 22, 2010 | Abandoned |
Array
(
[id] => 6102716
[patent_doc_number] => 20110166209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'COMPOSITIONS AND METHODS FOR AMELIORATING MYOSIN VIIA DEFECTS'
[patent_app_type] => utility
[patent_app_number] => 12/820333
[patent_app_country] => US
[patent_app_date] => 2010-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16692
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20110166209.pdf
[firstpage_image] =>[orig_patent_app_number] => 12820333
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/820333 | COMPOSITIONS AND METHODS FOR AMELIORATING MYOSIN VIIA DEFECTS | Jun 21, 2010 | Abandoned |
Array
(
[id] => 6518623
[patent_doc_number] => 20100261782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'INTRA-VASCULAR KIDNEY GENE THERAPY WITH PLASMID ENCODING BMP-7'
[patent_app_type] => utility
[patent_app_number] => 12/794184
[patent_app_country] => US
[patent_app_date] => 2010-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 24134
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20100261782.pdf
[firstpage_image] =>[orig_patent_app_number] => 12794184
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/794184 | Plasmid encoding feline BMP-7 | Jun 3, 2010 | Issued |
Array
(
[id] => 6614510
[patent_doc_number] => 20100310508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'METHODS OF TREATMENT INVOLVING p21/CIP1'
[patent_app_type] => utility
[patent_app_number] => 12/791577
[patent_app_country] => US
[patent_app_date] => 2010-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11748
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0310/20100310508.pdf
[firstpage_image] =>[orig_patent_app_number] => 12791577
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/791577 | Methods of treatment using a vector encoding p21/Cip1 | May 31, 2010 | Issued |
Array
(
[id] => 15915745
[patent_doc_number] => 10655103
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-19
[patent_title] => Equine progenitor cells
[patent_app_type] => utility
[patent_app_number] => 12/790389
[patent_app_country] => US
[patent_app_date] => 2010-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7541
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12790389
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/790389 | Equine progenitor cells | May 27, 2010 | Issued |
Array
(
[id] => 8209924
[patent_doc_number] => 20120129172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-24
[patent_title] => 'METHOD FOR SELECTING CLONE OF INDUCED PLURIPOTENT STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/375099
[patent_app_country] => US
[patent_app_date] => 2010-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9933
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20120129172.pdf
[firstpage_image] =>[orig_patent_app_number] => 13375099
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/375099 | Method for selecting clone of induced pluripotent stem cells | May 27, 2010 | Issued |
Array
(
[id] => 8221314
[patent_doc_number] => 20120135519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-31
[patent_title] => 'INDUCED DERIVATION OF SPECIFIC ENDODERM FROM hPS CELL-DERIVED DEFINITIVE ENDODERM'
[patent_app_type] => utility
[patent_app_number] => 13/322175
[patent_app_country] => US
[patent_app_date] => 2010-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7683
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13322175
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/322175 | INDUCED DERIVATION OF SPECIFIC ENDODERM FROM hPS CELL-DERIVED DEFINITIVE ENDODERM | May 27, 2010 | Abandoned |
Array
(
[id] => 6589405
[patent_doc_number] => 20100235928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'TRANSGENIC ANIMALS FOR ASSESSING DRUG METABOLISM AND TOXICITY'
[patent_app_type] => utility
[patent_app_number] => 12/787816
[patent_app_country] => US
[patent_app_date] => 2010-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 85
[patent_figures_cnt] => 85
[patent_no_of_words] => 34705
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20100235928.pdf
[firstpage_image] =>[orig_patent_app_number] => 12787816
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/787816 | Transgenic mice for assessing drug metabolism and toxicity | May 25, 2010 | Issued |
Array
(
[id] => 8227894
[patent_doc_number] => 20120142103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-07
[patent_title] => 'METHOD FOR INDUCING DIFFERENTIATION INTO EPITHELIAL PROGENITOR CELL/STEM CELL POPULATION AND CORNEAL EPITHELIAL CELL POPULATION FROM INDUCED PLURIPOTENT STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/321130
[patent_app_country] => US
[patent_app_date] => 2010-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11611
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13321130
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/321130 | METHOD FOR INDUCING DIFFERENTIATION INTO EPITHELIAL PROGENITOR CELL/STEM CELL POPULATION AND CORNEAL EPITHELIAL CELL POPULATION FROM INDUCED PLURIPOTENT STEM CELLS | May 17, 2010 | Abandoned |
Array
(
[id] => 6347738
[patent_doc_number] => 20100330666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'Vectors and Methods for Tissue Specific Synthesis of Protein in Eggs of Transgenic Hens'
[patent_app_type] => utility
[patent_app_number] => 12/779760
[patent_app_country] => US
[patent_app_date] => 2010-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9103
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0330/20100330666.pdf
[firstpage_image] =>[orig_patent_app_number] => 12779760
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/779760 | Vectors and Methods for Tissue Specific Synthesis of Protein in Eggs of Transgenic Hens | May 12, 2010 | Abandoned |
Array
(
[id] => 8807619
[patent_doc_number] => 08445270
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-21
[patent_title] => 'Immortalized avian cell lines and use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/777731
[patent_app_country] => US
[patent_app_date] => 2010-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 24
[patent_no_of_words] => 13312
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12777731
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/777731 | Immortalized avian cell lines and use thereof | May 10, 2010 | Issued |
Array
(
[id] => 8807619
[patent_doc_number] => 08445270
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-21
[patent_title] => 'Immortalized avian cell lines and use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/777731
[patent_app_country] => US
[patent_app_date] => 2010-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 24
[patent_no_of_words] => 13312
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12777731
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/777731 | Immortalized avian cell lines and use thereof | May 10, 2010 | Issued |
Array
(
[id] => 6505972
[patent_doc_number] => 20100216109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'METHOD AND APPARATUS FOR DRUG DELIVERY TO TISSUE OR ORGAN FOR TRANSPLANT'
[patent_app_type] => utility
[patent_app_number] => 12/776171
[patent_app_country] => US
[patent_app_date] => 2010-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9228
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20100216109.pdf
[firstpage_image] =>[orig_patent_app_number] => 12776171
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/776171 | METHOD AND APPARATUS FOR DRUG DELIVERY TO TISSUE OR ORGAN FOR TRANSPLANT | May 6, 2010 | Abandoned |